The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
460
Decision support tool for late preterm antenatal corticosteroids
Surrey Memorial Hospital
Surrey, British Columbia, Canada
RECRUITINGBC Women's Hospital
Vancouver, British Columbia, Canada
RECRUITINGThe change in frequency of clinical counselling about late preterm antenatal corticosteroids.
The difference in the proportion of patients who delivered a neonate at 34+0 to 36+6 weeks' gestation who report having had a discussion about antenatal corticosteroids with their care provider pre-intervention versus post-intervention.
Time frame: up to 8 months following implementation of the intervention.
The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale.
The difference in the average median score on the Combined Outcome Measure for Risk Communication and Treatment Decision Making Effectiveness (COMRADE) scale, among those that report having had a discussion about late preterm antenatal corticosteroids with their health care provider. We will use an adapted scale including 19 items, each of which are scored on a 5-point Likert scale. A higher score indicates better risk communication and treatment decision making effectiveness.
Time frame: up to 8 months following implementation of the intervention.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.